BLOG/🇺🇸United States··daily

S&P 500 Technology Sector SEC Filings — March 18, 2026

USA S&P 500 Technology

7 high priority3 medium priority10 total filings analysed

Executive Summary

Across these 10 filings from the S&P 500 Technology stream (broadly including software, blockchain, semis, and adjacent), Micron Technology dominates with record Q2 FY2026 revenue of $23.86B (+75% QoQ, +196% YoY) and raised Q3 guidance to $33.5B ±$0.75B at 81% margins, signaling robust semiconductor demand. Contrasting sharply, dMY Squared reported widened net losses to $17.8M YoY amid surging G&A (+310%) and ballooning liabilities (+268% YoY), highlighting SPAC unwind risks. M&A and restructuring themes emerge with RocketFuel's non-binding asset sale term sheet retaining cash reserves, BlockchAIn's completed business combo unlocking AI/HPC data center revenue ($22.9M in 2024), and Creative Media's massive 261M+ share dilution for preferred redemptions. Capital allocation leans positive with Micron's 30% dividend hike to $0.15/share (record date March 30, 2026), while equity grants to ACNB execs and board elections/stability at Pineapple and ImmuCell add low-materiality positives. Period-over-period trends show 1/10 with explosive growth (Micron), 1/10 with sharp deterioration (dMY), and neutral restructuring in 3/10; no broad insider selling patterns, but interested-party transactions flagged. Sector implications point to AI/semiconductor strength amid blockchain/AI infra deals, but dilution and loss-making entities pressure smaller tech names.

Tracking the trend? Catch up on the prior S&P 500 Technology Sector SEC Filings digest from March 17, 2026.

Investment Signals(10)

  • Record Q2 FY2026 revenue $23.86B (+75% QoQ from $13.64B, +196% YoY from $8.05B), GAAP gross margins 74.4% (up from 56.0% QoQ/36.8% YoY), raised dividend 30% to $0.15/share, Q3 guidance $33.5B ±$0.75B at ~81% margins

  • Completed business combo with Signing Day Sports and One Blockchain LLC on March 16, 2026; AI/HPC data center generated $22.9M revenue/$5.7M net income in 2024, expansions planned 2026-2027, trading as 'AIB' on NYSE American March 17

  • RocketFuel Blockchain(NEUTRAL-BULLISH)

    Non-binding term sheet for payments/loyalty assets sale, buyers assume $1.5M liabilities, earn-outs up to $2.5M, warrants for 20% ownership with $1.5M/$0.2M floors; retains cash reserves post-sale

  • 2026 Annual Meeting elected 6 directors with 79-91% support, ratified auditors at 86.8% (2.7M shares), all proposals passed decisively

  • Appointed Kathy Turner (ex-Elanco/IDEXX exec with 30+ yrs animal health exp) to Board effective April 1, 2026, as Compensation Chair/Audit member, replacing retiring director

  • ACNB Corp(BULLISH)

    Granted variable equity awards (3.1K-8.4K RSUs) to 5 key execs vesting 1/3 immediately/2027/2028 under 2018 Omnibus Plan

  • Net loss widened to $17.8M YoY from $0.8M, G&A +310% to $4.5M, liabilities +268% YoY to $27.2M, shareholders' deficit to $(27.0M) from $(6.8M), EPS $(4.55) from $(0.21)

  • Issued 261M+ Common shares (1.1M/51M Series A, 2.3M/206M Series A1, 0.6M Series D) for preferred redemptions March 12/16, 2026, at 20-day VWAP, potential major dilution

  • 10-K filing with medium risk/high materiality (8/10), signaling potential operational/financial shifts in immunopharma tech adjacent space

  • DEF 14A details strong governance (100% director attendance, anti-hedging/pledging policy), independent committees met 2-6x in 2025

Risk Flags(8)

Opportunities(8)

Sector Themes(5)

  • Semiconductor Boom(BULLISH IMPLICATION)

    Micron's 196% YoY revenue growth/74.4% margins outlier vs. sector; implies AI/memory demand surge, contrast dMY's SPAC woes

  • M&A/Restructuring in Blockchain/AI Infra(NEUTRAL-BULLISH)

    3/10 filings (RocketFuel, BlockchAIn, dMY) show asset sales/mergers; avg materiality 9.7/10, retaining cash while unlocking value

  • Dilution Pressures in Smaller Caps(BEARISH IMPLICATION)

    Creative Media 261M+ shares issued (100x+ potential float impact), echoes SPAC liability builds; 2/10 with equity issuances/grants

  • Capital Returns Modest(NEUTRAL)

    Only Micron raised dividend 30% to $0.15/share; ACNB RSUs align mgmt, no broad buybacks/splits, focus on reinvestment/growth

  • Governance Stability(BULLISH IMPLICATION)

    4/10 (Pineapple, ACNB, Community Trust, ImmuCell) with board elections/appointments/grants/meetings; 79-100% approvals, low opposition

Watch List(8)

Filing Analyses(10)
Estrella Immunopharma, Inc.10-Kmateriality 8/10

18-03-2026

ROCKETFUEL BLOCKCHAIN, INC.8-Kneutralmateriality 9/10

18-03-2026

RocketFuel Blockchain, Inc. entered a non-binding term sheet on March 13, 2026, with RPay, Inc. and RPoints, Inc. for the proposed sale of its payments business assets to RPay and loyalty/rewards business assets to RPoints. Consideration includes buyers assuming $1.5M in senior deferred compensation liabilities, quarterly earn-out payments of 20% of payments business net revenue up to $2.5M aggregate or 2 years, and warrants for 20% fully diluted ownership in each buyer with fixed repurchase floors of $1.5M (RPay) and $0.2M (RPoints). The Company retains its corporate franchise and cash reserves, with the Board approving the interested-party transaction; the term sheet is non-binding except for exclusivity, confidentiality, and fees.

  • ·Term Sheet filed as Exhibit 10.1
  • ·Anticipated execution of definitive asset purchase agreements
  • ·Transaction approved by Board despite interested nature
dMY Squared Technology Group, Inc.10-Knegativemateriality 9/10

18-03-2026

dMY Squared Technology Group, Inc. reported a sharply widened net loss of $17.8M for the year ended December 31, 2025, compared to $0.8M in 2024, driven by a $14.3M unfavorable change in fair value of derivative warrant liabilities (vs. $0.5M prior year) and general and administrative expenses surging 310% YoY to $4.5M. While cash and investments held in the Trust Account increased 6.7% YoY to $27.3M, operating cash plummeted nearly 100% to just $78 and total liabilities ballooned to $27.2M (up 268% YoY), primarily from warrant liabilities reaching $15.7M. Shareholders' deficit deteriorated to $(27.0M) from $(6.8M), reflecting remeasurements and conversions.

  • ·Class A common stock EPS basic declined to $(4.55) from $(0.21) YoY.
  • ·Accrued expenses rose to $4.2M from $0.8M as of Dec 31, 2025.
  • ·Convertible notes - related parties increased to $1.2M from $0.6M.
  • ·Advances from related parties jumped to $2.4M from $0.4M.
MICRON TECHNOLOGY INC8-Kpositivemateriality 10/10

18-03-2026

Micron Technology reported record Q2 FY2026 revenue of $23.86B, up 75% QoQ from $13.64B and 196% YoY from $8.05B, with GAAP net income of $13.79B ($12.07 diluted EPS) and non-GAAP net income of $14.02B ($12.20 EPS). All business units showed strong growth, with gross margins reaching 74.4% GAAP (74.9% non-GAAP) and operating cash flow of $11.90B. The company raised its quarterly dividend 30% to $0.15/share and guided Q3 revenue to $33.5B ±$0.75B with ~81% gross margins.

  • ·Q2 FY2026 GAAP gross margin of $17.755B (74.4% of revenue), up from 56.0% QoQ and 36.8% YoY.
  • ·Investments in capital expenditures, net: $5.0B for Q2 FY2026.
  • ·Quarterly dividend of $0.15 per share, payable April 15, 2026 to shareholders of record March 30, 2026.
  • ·Cash and equivalents: $13.908B as of Feb 26, 2026.
  • ·Total assets: $101.509B as of Feb 26, 2026.
Creative Media & Community Trust Corp8-K/Aneutralmateriality 8/10

18-03-2026

Creative Media & Community Trust Corporation (CMCT) filed an 8-K/A to disclose the number of Common Stock shares issued to satisfy Preferred Stock redemptions initiated prior to March 5, 2026, and those noticed on March 6, 2026. On March 12, 2026, the Company issued 1,106,594 Common shares for Series A Preferred redemptions and 2,322,421 for Series A1 Preferred redemptions; on March 16, 2026, it issued 51,027,328 for Series A, 206,166,177 for Series A1, and 594,090 for Series D Preferred redemptions, based on 20-day VWAP preceding each date. These issuances, totaling over 261 million Common shares, were exempt under Section 3(a)(9) of the Securities Act and may dilute existing shareholders.

  • ·Redemptions satisfied on March 12, 2026 for all Preferred Stock holder requests prior to March 5, 2026.
  • ·Issuances exempt from registration under Section 3(a)(9) of the Securities Act of 1933.
  • ·Common Stock trading symbol: CMCT on Nasdaq.
Pineapple Financial Inc.8-Kpositivemateriality 5/10

18-03-2026

At Pineapple Financial Inc.'s 2026 Annual Meeting of Stockholders on March 13, 2026, shareholders elected six directors—Shubha Dasgupta, Kendall Marin, Drew Green, Paul Baron, Tasis Giannoukakis, and Anthony Georgiades—each receiving majority support ranging from approximately 79% (Dasgupta and Georgiades) to 91% (others). Shareholders also ratified MNP LLP as the independent auditors for the fiscal year ending August 31, 2026, with 86.8% votes in favor (2,709,116.09 shares). While all proposals passed decisively, Dasgupta and Georgiades faced relatively higher opposition with around 180,000 votes against each.

  • ·Meeting results filed on March 18, 2026
  • ·Company is an emerging growth company
  • ·Common Shares traded as PAPL on NYSE American
BlockchAIn Digital Infrastructure, Inc.8-Kpositivemateriality 10/10

18-03-2026

BlockchAIn Digital Infrastructure, Inc. completed a business combination with Signing Day Sports, Inc. and One Blockchain LLC on March 16, 2026, positioning BlockchAIn Inc. as the parent company set to commence trading under ticker 'AIB' on NYSE American on March 17, 2026. One Blockchain LLC, focused on HPC and AI hosting, operates a 40 MW data center in South Carolina that generated $22.9M in revenue and $5.7M in net income in 2024, with planned AI data center expansions in 2026 and 2027. No comparative period declines or flat metrics were reported.

  • ·Registration Statement on Form S-4 filed December 1, 2025, declared effective January 30, 2026
  • ·Proxy statement/prospectus filed February 17, 2026
ACNB CORP8-Kpositivemateriality 6/10

18-03-2026

On March 13, 2026, the Boards of Directors of ACNB Corporation and ACNB Bank granted Variable Equity Awards of restricted stock to five key executive officers under the ACNB Bank Variable Compensation Plan and ACNB Corporation 2018 Omnibus Stock Incentive Plan. Awards ranged from 3,131.93 shares to 8,419.43 shares per executive, with no prior period comparisons available in the filing. Vesting occurs in one-third increments: immediately on grant date, January 1, 2027, and January 1, 2028.

  • ·Awards subject to forfeiture restrictions upon termination of employment and terms in the Employee Award Agreement.
  • ·Plans and Employee Award Agreement filed as Exhibits 99.1, 99.2, and 99.3.
COMMUNITY TRUST BANCORP INC /KY/DEF 14Aneutralmateriality 6/10

18-03-2026

CTBI's DEF 14A proxy statement, filed March 18, 2026, details board governance, committee structures, and 2025 activities, including a policy prohibiting directors and executives from hedging or pledging significant CTBI equity securities (lesser of 1% outstanding or 50% owned). The Board held 6 meetings in 2025, with all directors attending at least 75% of Board and committee meetings and the 2025 Annual Meeting. Independent committees such as Audit (chaired by Eugenia Crittenden “Crit” Luallen, audit financial expert), Compensation, Nominating, Risk and Compliance oversee key risks and functions via enterprise-wide risk management.

  • ·All Audit Committee members meet Nasdaq independence and qualifications standards.
  • ·Compensation Committee met twice in 2025.
  • ·Nominating and Corporate Governance Committee met twice in 2025.
  • ·Risk and Compliance Committee met four times in 2025 and receives quarterly risk reports.
  • ·Enterprise-wide risk management (EWRM) overseen by Board committees including Audit and Risk and Compliance.
IMMUCELL CORP /DE/8-Kpositivemateriality 6/10

18-03-2026

ImmuCell Corporation (Nasdaq: ICCC) appointed Kathy Turner, former Elanco Animal Health board member and IDEXX Laboratories executive, to its Board of Directors effective April 1, 2026, replacing Steven Rosgen who is retiring after 8 years of service since January 2018. Turner will serve as Chair of the Compensation and Stock Option Committee and a member of the Audit Committee, bringing over 30 years of experience in healthcare and animal health. No financial metrics or impacts were disclosed in the announcement.

  • ·Kathy Turner previously served on the Board of Directors of Elanco Animal Health.
  • ·At IDEXX Laboratories, Turner was Chief Marketing Officer and Senior Vice President of International Operations, contributing to double-digit growth in international markets.
  • ·Turner currently serves on the Board of Veterinarians Without Borders.
  • ·Contacts: investor.relations@immucell.com and iccc@lythampartners.com

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 10 filings

🇺🇸 More from United States

View all →
S&P 500 Technology Sector SEC Filings — March 18, 2026 | Gunpowder Blog